Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Severe case 46% Improvement Relative Risk Vitamin D for COVID-19  Ozturk et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 300 patients in Turkey Lower severe cases with higher vitamin D levels (not stat. sig., p=0.1) c19early.org Ozturk et al., Bratislava Medical J., May 2022 Favors vitamin D Favors control

Is there a relationship between vitamin D levels, inflammatory parameters, and clinical severity of COVID-19 infection?

Ozturk et al., Bratislava Medical Journal, doi:10.4149/BLL_2022_065
May 2022  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Retrospective 300 hospitalized patients in Turkey with vitamin D levels measured with 6 months before admission, showing no significant difference in severity based on vitamin D deficiency.
This is the 135th of 196 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 11,637 vigintillion).
This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of severe case, 46.4% lower, RR 0.54, p = 0.10, high D levels (≥20ng/mL) 9 of 110 (8.2%), low D levels (<20ng/mL) 29 of 190 (15.3%), NNT 14.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ozturk et al., 16 May 2022, retrospective, Turkey, peer-reviewed, 6 authors. Contact: drgul_can@hotmail.com.
This PaperVitamin DAll
Is there a relationship between vitamin D levels, inflammatory parameters, and clinical severity of COVID-19 infection?
MD Gulcan Ozturk, Berrin Zinnet Eraslan, Pinar Akpinar, Duygu Karamanlioglu silte, Feyza Ozkan unlu, Ilknur Aktas
Bratislava Medical Journal, doi:10.4149/bll_2022_065
OBJECTIVES: This study is aimed to determine the relationship between 25-OH vitamin D levels, infl ammatory parameters of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), c-reactive protein (CRP) levels and the disease severity of COVID-19 infection. BACKGROUND: Infl ammation plays a key role in the pathogenesis of COVID-19 while identifying the clinical course and prognosis. The effect of vitamin D defi ciency on contribution to infl ammation in COVID-19 is unclear. METHODS: Based on the classifi cation of the clinical course of COVID-19, the patients were divided into three groups, i.e., with mild (Group 1), moderate (Group 2) and severe/critical cases (Group 3). The 25-OH vitamin D values were defi ned as defi cient, insuffi cient or normal. RESULTS: There were no statistically signifi cant differences in the distribution rates of 25-OH vitamin D levels (p>0.05) between the groups. Infl ammatory parameters in Group 3 were statistically signifi cantly higher as compared to Groups1 and 2 (p < 0.05). Multivariate logistic regression analysis revealed that NLR was an independent predictor of disease severity. CONCLUSION: There is no relationship between the severity of COVID-19 infection and 25-OH vitamin D defi ciency. Infl ammatory parameters are associated with the disease severity, while NLR is an independent predictor of severe COVID-19. There was no correlation between 25-OH vitamin D and infl ammatory markers (Tab. 4, Fig. 1, Ref. 38).
References
Akbas, Gungor, Ozcicek, Akbas, Askin et al., Vitamin D and infl ammation: Evaluation with neutrophilto-lymphocyte ratio and platelet-to-lymphocyte ratio, Arch Med Sci
Ali, Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19, J Med Virol
Ali, Role of vitamin D in preventing of COVID-19 infection, progression and severity, J Infect Public Health
Alipio, Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus, SSRN Journal
Altaş, Tosun, Assessment of Vitamin D and infl ammatory response relationship using neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and mean platelet volume, Turk Osteoporoz Derg
Asan, Üstündağ, Koca, Do initial hematologic indices predict the severity of covid-19 patients? Turkish, J Med Sci
Aygun, Vitamin D can prevent COVID-19 infection-induced multiple organ damage, Naunyn Schmiedebergs Arch Pharmacol
Baktash, Hosack, Patel, Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J
Chan, Rout, Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19, J Clin Med Res
Chandran, Maung, Mithal, Parameswaran, Vitamin D in COVID -19: Dousing the fi re or averting the storm? -A perspective from the Asia-Pacifi c, Osteoporos Sarcopenia
Charoenngam, Shirvani, Holick, Vitamin D and Its Potential Benefi t for the COVID-19 Pandemic, Endocr Pract
Daneshkhah, Agrawal, Eshein, Subramanian, Roy et al., The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients, medRxiv
Ebadi, Montano-Loza, Perspective: improving vitamin D status in the management of COVID-19, Eur J Clin Nutr
Ferrari, Locatelli, Briguglio, Lombardi, Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity?, Cell Biochem Funct
Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that vitamin d supplementation could reduce risk of infl uenza and covid-19 infections and deaths, Nutrients
Guideline, Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial version 7), Chin Med J (Engl)
Hastie, Mackay, Ho, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr Clin Res Rev
Hedlund, Diamond, Uversky, The latitude hypothesis, vitamin D, and SARS-Co-V2, J Biomol Struct Dyn
Kara, Soylu, The relationship between vitamin D and infl ammatory markers in maintenance hemodialysis patients, Int Urol Nephrol
Karahan, Katkat, Impact of Serum 25 (OH) Vitamin D Level on Mortality in Patients with COVID-19 in Turkey, J Nutr Heal Aging
Khemka, Suri, Singh, Bansal, Role of Vitamin D Supplementation in Prevention and Treatment of COVID-19, Indian J Clin Biochem
Kong, Zhang, Cao, Mao, Lu, Higher level of Neutrophilto-Lymphocyte is associated with severe COVID-19, Epidemiol Infect
Lau, Majumder, Torabi, Saeg, Hoffmanet et al., Vitamin D insuffi ciency is prevalent in severe CO-VID-19, medRxiv
Li, Li, Zhang, Liu, Sunlight and vitamin D in the prevention of coronavirus disease (COVID-19) infection and mortality in the United States
Liefaard, Ligthart, Vitezova, Vitamin D and C-reactive protein: A mendelian randomization study, PLoS One
Lippi, Plebani, Henry, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis, Clin Chim Acta
Mendy, Apewokin, Wells, Morrow, Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients, medRxiv
Mok, Ng, Ahidjo, Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis
Qin, Ma, Tang, Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of infl ammatory response and disease activity in SLE patients, Mod Rheumatol
Qun, Wang, Chen, Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19, Front Immunol
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D defi ciency and outcome of COVID-19 patients, Nutrients
Raisi-Estabragh, Mccracken, Bethell, Greater risk of severe COVID-19 in black, asian and minority ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25 (OH)-vitamin D status: Study of 1326 cases from the UK biobank, J Public Heal (Oxf)
Seyit, Avci, Nar, Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19, Am J Emerg Med
Shang, Dong, Ren, Tian, Li et al., The value of clinical parameters in predicting the severity of COVID-19, J Med Virol
Teymoori-Rad, Marashi, Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions, Rev Med Virol
Wang, Li, Shang, Ratios of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Predict All-Cause Mortality in Inpatients with Coronavirus Disease 2019 (COVID-19): A Retrospective Cohort Study in A Single Medical Center, Epidemiol Infect
Xu, Baylink, Chen, The importance of Vitamin D metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19, J Transl Med
Yildirim, Hur, Kokturk, Infl ammatory markers: C-reactive protein, erythrocyte sedimentation rate, and leukocyte count in vitamin D defi cient patients with and without chronic kidney disease, Int J Endocrinol
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit